TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma
Clinical trial NCT01039025 · COMPLETED
Trial details
- NCT number
- NCT01039025
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-02-18
- Primary completion
- 2006-05-19
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.